Oliver Bogler logo The University of Texas MD Anderson Cancer Center logo

Oliver Bogler

Senior Vice President for Academic Affairs, VP, Global Academic Programs & Professor, Neurosurgery-Research, The University of Texas, MD Anderson Cancer Center (USA)


Dr. Bogler studied Natural Sciences at Cambridge University and completed his PhD from the Ludwig Institute for Cancer Research in London, UK in 1991. Following post-doctoral training at the Salk Institute, and the Ludwig Institute, San Diego Branch, he held faculty appointments at Virginia Commonwealth University (1997-2000) and Henry Ford Hospital (2000-2005). In 2005 he joined UT MD Anderson Cancer Center as Director of Basic Research for the Brain Tumor Center. His research focused on EGFR signaling and novel platinum compounds in glioma. In 2010 he became Vice President for Global Academic Programs and manages international academic relationships behalf of MD Anderson. In 2011 he was also appointed Senior Vice President for Academic Affairs, and oversees 320 people organized into 15 departments, who deliver support for the more than 5,000 academic personnel at MD Anderson and are the stewards of our education mission.


Why WIN

The WIN consortium is the premier venue for innovative, international clinical research in cancer and is visionary in its inclusive membership and focus on personalized medicine.

Oliver Bogler logo

Oliver Bogler

Senior Vice President for Academic Affairs, VP, Global Academic Programs & Professor, Neurosurgery-Research, The University of Texas, MD Anderson Cancer Center (USA)


The University of Texas MD Anderson Cancer Center logo

Dr. Bogler studied Natural Sciences at Cambridge University and completed his PhD from the Ludwig Institute for Cancer Research in London, UK in 1991. Following post-doctoral training at the Salk Institute, and the Ludwig Institute, San Diego Branch, he held faculty appointments at Virginia Commonwealth University (1997-2000) and Henry Ford Hospital (2000-2005). In 2005 he joined UT MD Anderson Cancer Center as Director of Basic Research for the Brain Tumor Center. His research focused on EGFR signaling and novel platinum compounds in glioma. In 2010 he became Vice President for Global Academic Programs and manages international academic relationships behalf of MD Anderson. In 2011 he was also appointed Senior Vice President for Academic Affairs, and oversees 320 people organized into 15 departments, who deliver support for the more than 5,000 academic personnel at MD Anderson and are the stewards of our education mission.


Why WIN

The WIN consortium is the premier venue for innovative, international clinical research in cancer and is visionary in its inclusive membership and focus on personalized medicine.